Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by University of Pittsburgh
Sponsor:
Collaborator:
Hemispherx Biopharma
Information provided by (Responsible Party):
Pawel Kalinski, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01545141
First received: February 29, 2012
Last updated: April 25, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)